Sonnet BioTherapeutics Holdings, Inc. Recorded Big Gain
Wed, Jan 22, 2025 at 07:40 PM
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) soared at $2, a gain of 29.9%. On Wed, Jan 22, 2025, SONN:NASDAQ touched a New 2-Week High of $2. The stock got featured on our News Catalysts scanner on Wed, Jan 22, 2025 at 10:32 AM in the 'MISCELLANEOUS' category. From Wed, Jan 08, 2025, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Mon, Jan 06, 2025 at $2.52 with a volume of 1M+.
About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)
Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.
Top 10 Gainers:
- Asset Entities Inc. (ASST:NASDAQ), 51.11%
- Jayud Global Logistics Limited (JYD:NASDAQ), 42.51%
- Mobix Labs Inc. (MOBX:NASDAQ), 40.68%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%
- Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ), 35.44%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 33.53%
- Rekor Systems, Inc. (REKR:NASDAQ), 32.48%
- PTL LTD (PTLE:NASDAQ), 31.69%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 30.73%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 29.87%